Regulatory Updates
Aug 30, 2026•1 min read
Korean Hospital Pharmacists Association Prioritizes Ward‑Dedicated Pharmacist System for Patient Safety
The association named the implementation of ward‑dedicated pharmacists and activation of specialist pharmacist roles as key initiatives for the second half of the year, emphasizing their importance for preventing medication‑related safety incidents.
Regulatory Updates
Aug 30, 2026•1 min read
KRPIA Welcomes Korea’s First International Joint Drug Review via EMA’s OPEN Program
The Korea Research-based Pharmaceutical Industry Association (KRPIA) praised the MFDS for completing its first joint drug assessment with overseas regulators through EMA’s OPEN program, conducted simultaneously in Europe and Korea.
Regulatory Updates
Aug 30, 2026•1 min read
Korean Pharma Association to Host Online Forum on Hair‑Loss Drug Insurance Coverage
An online Zoom discussion on June 25 will examine the government's plan to include hair‑loss treatments in national health insurance and related coverage principles.
Regulatory Updates
Aug 30, 2026•1 min read
MFDS reviews removal of pediatric indication for dioctahedralsmektate antidiarrheal
South Korea’s MFDS is considering deleting the pediatric indication for the dioctahedralsmektate antidiarrheal after safety data were deemed insufficient, following proactive applications by manufacturers.
1
Regulatory Updates
Aug 30, 2026•1 min read
Daegu Pharmacists Host 2026 Farm Fair & Mandatory Training
Pharmacists gathered at Daegu EXCO for the 2026 Daegu City Pharmacist Farm Fair and required continuing education, highlighting improved training quality and regulatory compliance.
Regulatory Updates
Aug 30, 2026•1 min read
Korea advances legal framework for medical cannabis to aid rare disease patients
A policy forum at the National Assembly discussed establishing a legal basis for introducing and producing cannabis‑derived medicines to ensure stable supply for rare and intractable disease patients.
Regulatory Updates
Aug 30, 2026•1 min read
South Korea bans pediatric use of Daewoong's Starvic and Daewon's Potagel suspensions
Daewoong’s Starvic and Daewon’s Potagel pediatric diarrhea suspensions are prohibited nationwide in Korea effective July 6, after MFDS found insufficient safety data for children.
Regulatory Updates
Aug 30, 2026•1 min read
Health Insurance Co‑Payment Cap Beneficiaries Rise 6.5% Annually, Costs Climb
Supporters of Korea's health‑insurance co‑payment cap grew by an average 6.5% per year, reaching 2.135 million in 2025 with expenditures of 2.792 trillion KRW.
Regulatory Updates
Aug 30, 2026•1 min read
경방신약, 기준서 미준수로 의약품 제조 1개월 정지
경방신약이 제조관리기준서 등 지시서 미준수로 식품의약품안전처로부터 7월 한 달간 두 품목 제조 정지 처분을 받았다.
15
Regulatory Updates
Aug 30, 2026•1 min read
Korean Parliament Proposes Stricter OTC Drug Sales Controls and Medication Guidance
New bills aim to tighten OTC drug sales to minors and require pharmacies to keep sales records, sparking debate over added burdens on pharmacies.
Regulatory Updates
Aug 30, 2026•1 min read
2027 Minimum Wage Talks Resume; Pharmacies Monitor Labor Cost Implications
The 12th full meeting of the Minimum Wage Committee will resume on the 7th to discuss the 2027 wage, with pharmacies closely watching the outcome for staffing cost planning.
1
Regulatory Updates
Aug 30, 2026•1 min read
Korean Pharmacy Information Center Extends PM+20 Conversion Deadline
The Pharmacy Information Center announced an extension of the PM+20 conversion deadline after partner companies and member pharmacies reported capacity constraints and a surge in requests during the July‑August vacation period.